Stock NKTX NKARTA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

MarketScreener Strategies Nkarta, Inc.

Equities

NKTX

US65487U1088

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-07-12 pm EDT 		5-day change 1st Jan Change
6.51 USD +0.70% Intraday chart for Nkarta, Inc. +25.68% -1.36%
Jun. 27 Nkarta Initiates Trial of Cell Therapy to Treat Lupus Nephritis; FDA Clears Second Application MT
Jun. 27 Nkarta, Inc. Initiates Clinical Trial of NKX019 in Lupus Nephritis with First Patient in Screening and Announces Pipeline Expansion to Additional Autoimmune Indications CI

MarketScreener Strategies

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NKTX Stock
  4. News Nkarta, Inc.
  5. MarketScreener Strategies